The MFDS manages biologics registration through a rigorous process that includes preclinical and clinical trial evaluations, safety and efficacy assessments, and manufacturing inspections. Applicants must submit detailed data on the biologic’s quality, safety, and effectiveness. Post-market surveillance ensures continued compliance with safety standards and product monitoring.